—

Biogen Inc (BIIB) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +11.1% vs the 50-day and +25.7% vs the 200-day average, 1.7% below the 52-week high and +71.3% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
  • Trend: Biogen Inc trades 11.1% above its 50-day and 25.7% above its 200-day moving average. (as of 2026-11-04)

Biogen discovers, develops and sells medicines for neurological, immune and rare conditions, largely outside the AI-linked sectors the diary tracks. Its portfolio includes multiple sclerosis treatments such as Tecfidera and Tysabri, the Alzheimer's drug Leqembi, and biosimilar versions of established antibody therapies.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BIIB overview. Research diary readings, not advice.

Uptrend stack intact

Trades +11.1% vs the 50-day and +25.7% vs the 200-day average, 1.7% below the 52-week high and +71.3% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on BIIB?

Uptrend stack intact — Trades +11.1% vs the 50-day and +25.7% vs the 200-day average, 1.7% below the 52-week high and +71.3% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BIIB above its 50-day and 200-day moving averages?

As of 2026-11-04, Biogen Inc trades +11.1% above its 50-day and +25.7% above its 200-day average, with the 20-day +5.4% away.

How far is BIIB from its 52-week high?

1.7% below the 52-week high and 71.3% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.